The impact of inflammatory biomarkers on amputation rates in patients with diabetic foot ulcers

• Published in: International wound journal Vol. 21; no. 4; pp. e14827 - n/a
• Main Authors: Xu, Yun, Geng, Ruina, Meng, Xiangyu, Feng, Zhipeng, Wang, Xu, Zhang, Guanying, Bai, Liwei
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.04.2024
• Subjects: amputation risk; diabetic foot ulcers; haematological inflammatory markers; neutrophil‐to‐lymphocyte ratio; Original; platelet‐to‐lymphocyte ratio; haematological inflammatory markers; platelet‐to‐lymphocyte ratio; diabetic foot ulcers; neutrophil‐to‐lymphocyte ratio; amputation risk
• ISSN: 1742-4801; 1742-481X
• DOI: 10.1111/iwj.14827

Diabetic Foot Ulcers (DFUs) are a major complication of diabetes, often leading to amputation. Understanding the relationship between haematological inflammatory markers and the incidence of amputation in DFU patients with infectious complications is crucial for improving management and outcomes. This retrospective study, conducted from May 2020 to October 2022, involved 109 patients with DFUs, categorised into amputation (AM) and non‐amputation (NAM) groups. Patients were evaluated for various factors, including demographic data, DFU duration, and blood parameters such as haemoglobin A1c (HbA1c), haemoglobin (Hb), albumin (ALB), white blood cell count (WBC), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), C‐reactive protein (CRP), platelet‐to‐lymphocyte ratio (PLR), neutrophil‐to‐lymphocyte ratio (NLR), and lymphocyte‐to‐monocyte ratio (LMR). Statistical analyses were performed using independent sample t‐tests, Mann–Whitney U test and logistic regression. The univariate analysis showed no significant difference in BMI, DM duration or DFU duration between groups. However, significant differences were noted in PCT, Hb, ESR, ALB, HbA1c and WBC levels, and in inflammatory ratios (NLR, PLR and LMR). Multivariate logistic regression identified CRP, NLR and PLR as independent risk factors for amputation. The study highlights CRP, PLR and NLR as key independent risk factors for amputation in patients with DFUs. These easily obtainable markers from routine blood tests can effectively aid in predicting the risk of osteomyelitis and amputation, enhancing clinical decision making and patient care strategies.